← ANALYST RATINGS · TIPRANKS
Medtronic (MDT): analyst forecast and price target
Analyst consensus
Moderate Buy5 Buy7 Hold0 Sell
Ratings of 12 analysts in the last 3 months · top analysts only12-month forecast
Based on 12 price targets given in the last 3 months, the average target is $103, the highest $115, the lowest $92.00. The average is +9.1% from the last price of $94.75.
Analyst ratings 27
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | — | Hold | — | Reiterated | 16.10.26on TipRanks 07:55 | +0.4% | ↗ |
| Matthew O'Brien★★★★★★★★★★#12031 · hits 41% · avg −4.5% | Piper Sandler | $85.00 | Hold | −10.3% | Reiterated | 14.10.26on TipRanks 07:25 | +2.4%next day +1.0% | ↗ |
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | $100 → $99.00−1.0% | Buy | +4.5% | Reiterated | 12.10.26on TipRanks 08:40 | +4.0%next day +1.2% | ↗ |
| Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% | Barclays | $95.00 | Hold | +0.3% | Initiated | 06.10.26on TipRanks 16:35 | −1.6%next day +3.0% · 5 days +11.2% | ↗ |
| Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% | Citi | $110 | Buy | +16.1% | Reiterated | 05.10.26on TipRanks 08:02 | +1.2%next day −1.6% · 5 days +4.1% | ↗ |
| Name not given | — | $118 | Buy | +24.5% | Reiterated | 01.10.26on TipRanks Oct 2 21:45 | 0.0%next day −0.8% · 5 days +0.2% | ↗ |
| Josh Jennings★★★★★★★★★★#3537 · hits 46% · avg +3.0% | TD Cowen | $110 | Buy | +16.1% | Reiterated | 30.09.26on TipRanks 02:00 | −0.7%next day 0.0% · 5 days −2.8% | ↗ |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | $114 | Buy | +20.3% | Reiterated | 17.09.26on TipRanks 06:08 | −1.0%next day −0.8% · 5 days −5.4% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $107 → $108+0.9% | Buy | +14.0% | Reiterated | 15.09.26on TipRanks 09:06 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $105 → $106+1.0% | Buy | +11.9% | Reiterated | 15.09.26on TipRanks 09:06 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $107 → $106−0.9% | Buy | +11.9% | Reiterated | 15.09.26on TipRanks 09:06 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $107 | Buy | +12.9% | Reiterated | 15.09.26on TipRanks 09:06 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $110 | Buy | +16.1% | Reiterated | 15.09.26on TipRanks 09:06 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $109 | Buy | +15.0% | Reiterated | 15.09.26on TipRanks 09:06 | — | |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $110 | Buy | +16.1% | Reiterated | 14.09.26on TipRanks 06:25 | +3.6%next day +0.4% · 5 days −4.1% | ↗ |
| Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% | William Blair | — | Buy | — | Reiterated | 10.09.26on TipRanks 16:25 | −1.6%next day +3.6% · 5 days +1.4% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $104 | Buy | +9.8% | Reiterated | 09.09.26on TipRanks Sep 10 05:31 | −0.1%next day +0.3% · 5 days +1.9% | ↗ |
| Pito Chickering★★★★★★★★★★#1500 · hits 61% · avg +9.8% | Deutsche Bank | $78.00 → $92.00+17.9% | Hold | −2.9% | Assigned | 03.09.26on TipRanks 08:40 | −0.1%next day +1.5% · 5 days −1.1% | ↗ |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $100 → $110+10.0% | Buy | +16.1% | Assigned | 03.09.26on TipRanks 08:00 | −0.1%next day +1.5% · 5 days −1.1% | ↗ |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $100 → $115+15.0% | Buy | +21.4% | Reiterated | 02.09.26on TipRanks 15:20 | −0.3%next day −0.1% · 5 days +0.3% | ↗ |
| Jayson Bedford★★★★★★★★★★#819 · hits 60% · avg +8.6% | Raymond James | — | Hold | — | Reiterated | 02.09.26on TipRanks 09:10 | −0.3%next day −0.1% · 5 days +0.3% | ↗ |
| Matthew Taylor★★★★★★★★★★#1367 · hits 55% · avg +7.2% | Jefferies | $95.00 | Hold | +0.3% | Reiterated | 02.09.26on TipRanks 08:50 | −0.3%next day −0.1% · 5 days +0.3% | ↗ |
| Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% | Truist Financial | $86.00 → $99.00+15.1% | Hold | +4.5% | Reiterated | 02.09.26on TipRanks 07:30 | −0.3%next day −0.1% · 5 days +0.3% | ↗ |
| Rick Wise★★★★★★★★★★#7800 · hits 51% · avg +0.1% | Stifel Nicolaus | $80.00 → $95.00+18.8% | Hold | +0.3% | Reiterated | 02.09.26on TipRanks 06:40 | −0.3%next day −0.1% · 5 days +0.3% | ↗ |
| David Rescott★★★★★★★★★★#3448 · hits 49% · avg +5.1% | Robert W. Baird | $91.00 → $100+9.9% | Hold | +5.5% | Reiterated | 02.09.26on TipRanks 06:40 | −0.3%next day −0.1% · 5 days +0.3% | ↗ |
| Mike Kratky★★★★★★★★★★#1691 · hits 46% · avg +12.9% | Leerink Partners | — | Buy | — | Reiterated | 10.07.26on TipRanks 13:15 | +1.4%next day +0.4% · 5 days +0.7% | ↗ |
| Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% | Evercore ISI | $106 → $105−0.9% | Buy | +10.8% | Reiterated | 06.07.26on TipRanks 08:50 | −1.0%next day +1.4% · 5 days +0.9% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | $84.00 → $83.00−1.2% | Hold | −12.4% | Reiterated | 04.06.26on TipRanks Jun 5 08:15 | +4.7%next day +2.3% · 5 days +0.6% | ↗ |
| Lee Hambright★★★★★★★★★★#10167 · hits 49% · avg −1.6% | Bernstein | $112 → $97.00−13.4% | Buy | +2.4% | Reiterated | 04.06.26on TipRanks Jun 5 08:07 | +4.7%next day +2.3% · 5 days +0.6% | ↗ |
| David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% | Argus Research | $125 → $115−8.0% | Buy | +21.4% | Reiterated | 06.04.26on TipRanks 09:10 | −0.9%next day +0.1% · 5 days −2.1% | ↗ |
| Nico Chen★★★★★★★★★★#2913 · hits 59% · avg +9.8% | DBS | $90.00 | Hold | −5.0% | Reiterated | 18.03.26on TipRanks Mar 19 07:20 | 0.0%next day −0.1% · 5 days +1.2% | ↗ |
| Unknown Analyst | CICC | $121 | Buy | +27.7% | Initiated | 30.01.26on TipRanks Jan 31 06:25 | +2.2%next day −0.7% · 5 days +0.1% | ↗ |
| Christopher Pasquale★★★★★★★★★★#1776 · hits 61% · avg +11.9% | Nephron | $120 | Buy | +26.6% | Upgrade | 08.12.25on TipRanks 11:35 | +0.2%next day −1.5% · 5 days −2.2% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Medtronic
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $103 at a price of $86.29 (+19.8%); now: $103 at $94.75 (+8.9%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 1 | 0 | 0 |
| Buy | 17 | 20 | 18 | 21 | 21 | 16 |
| Hold | 6 | 8 | 5 | 5 | 7 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 24.11.26 (Q2 2027, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.33 (from $1.32 to $1.39). Last quarter: $1.45.
Sales
Next quarter’s sales estimate — $9.5B (from $9.4B to $9.5B). Last quarter: $9.8B.
Best top-analyst consensus in the sector · Healthcare
About Medtronic
- CEO: Geoffrey Straub Martha
- Employees: 95,000
- Building Two, Parkmore Business Park West, Galway, GA, H91 4K49, IE
- www.medtronic.com
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Med
Data from the stock’s TipRanks forecast page, read 15 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗